Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Keehoon Jung

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2199-5292; OpenAlex author ID A5012765342. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 7 papers

Papers 9

  1. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes. Co-author DOI 10.1038/s43018-022-00479-7↗
  2. Author Correction: Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtype… Co-author DOI 10.1038/s43018-023-00581-4↗
  3. Whole exome sequencing and RNA sequencing analyses of PDAC samples Co-author DOI 10.21203/rs.3.pex-2062/v1↗
  4. Mass spectrometry-based proteomic analysis of PDAC samples Co-author DOI 10.21203/rs.3.pex-2063/v1↗
  5. Bioinformatics analysis of PDAC subtypes Co-author DOI 10.21203/rs.3.pex-2064/v1↗
  6. Cell-based assays for potential prognostic biomarkers in PDAC Co-author DOI 10.21203/rs.3.pex-2065/v1↗
  7. Assays for orthotopic PDAC mouse models Co-author DOI 10.21203/rs.3.pex-2066/v1↗
  8. PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer. Last author DOI 10.1038/s41467-022-33991-6↗
  9. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Co-author DOI 10.1158/2159-8290.cd-15-1177↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Do Young Hyeon · 8 shared papers, 2022–2023 · strength 0.97
  2. Duk Ki Kim · 8 shared papers, 2022–2023 · strength 0.97
  3. Min‐Sik Kim · 7 shared papers, 2023 · strength 0.83
  4. Sangyeop Hyun · 7 shared papers, 2023 · strength 0.83
  5. Sung Hee Baek · 7 shared papers, 2023 · strength 0.83
  6. Hongbeom Kim · 7 shared papers, 2023 · strength 0.83
  7. Sang‐Won Lee · 7 shared papers, 2023 · strength 0.83
  8. Ja‐Lok Ku · 7 shared papers, 2023 · strength 0.83
  9. Taesung Park · 7 shared papers, 2023 · strength 0.83
  10. Gibeom Kim · 7 shared papers, 2023 · strength 0.83
  11. Daechan Park · 7 shared papers, 2023 · strength 0.83
  12. Wooil Kwon · 7 shared papers, 2023 · strength 0.83
  13. Jin‐Young Jang · 5 shared papers, 2023 · strength 0.59
  14. Jin‐Young Jang · 3 shared papers, 2022–2023 · strength 0.38
  15. Rakesh K. Jain · 1 shared paper, 2016 · strength 0.04
  16. João Incio · 1 shared paper, 2016 · strength 0.04
  17. Yves Boucher · 1 shared paper, 2016 · strength 0.04
  18. Theodoros P. Michelakos · 1 shared paper, 2016 · strength 0.04
  19. Nuh N. Rahbari · 1 shared paper, 2016 · strength 0.04
  20. Dai Fukumura · 1 shared paper, 2016 · strength 0.04
  21. Jelena Grahovac · 1 shared paper, 2016 · strength 0.04
  22. Cristina Rosa Ferrone · 1 shared paper, 2016 · strength 0.04
  23. Hao Liu · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.